The Department of Health (DHH) submits the attached response to HR 164. HR 164 directed LDH to study the most effective means by which to ensure open access to HIV/AIDS and hepatitis C medications for persons enrolled in the Medicaid managed care program known as “Bayou Health” and to submit its findings of the study to the House Committee on Health and Welfare.